Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18688793 | 0.96 | RXFP1 (0.48) | MEN1KMT2ACYP2C9RXFP1ALDH1A1 | |
| SCHEMBL18688795 | 0.94 | LMNA (0.45) | MEN1KMT2ACYP2C9RXFP1ALDH1A1 | |
| SCHEMBL18689403 | 0.89 | MAPT (0.51) | MEN1KMT2AALDH1A1LMNAHTT | |
| SCHEMBL18688791 | 0.88 | KMT2A (0.50) | MEN1KMT2AALDH1A1PKM | |
| SCHEMBL18689399 | 0.86 | MAPT (0.50) | MEN1KMT2AALDH1A1LMNAHTT | |
| SCHEMBL18689411 | 0.86 | THRB (0.49) | MEN1KMT2AALDH1A1LMNAHTT | |
| SCHEMBL18688805 | 0.85 | MAPT (0.54) | MEN1KMT2AALDH1A1HTTTSHR | |
| SCHEMBL18688796 | 0.85 | ALDH1A1 (0.50) | MEN1KMT2AALDH1A1LMNAHTT | |
| SCHEMBL18689423 | 0.85 | KMT2A (0.49) | MEN1KMT2AALDH1A1LMNAPKM | |
| SCHEMBL18689397 | 0.83 | TP53 (0.44) | MEN1KMT2AALDH1A1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353156-B1 | TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS | MASSACHUSETTS GEN HOSPITAL (US) | 2021-11-03 | — | — | EP | disclosed |
| US-10696642-B2 | TEAD transcription factor autopalmitoylation inhibitors | THE GENERAL HOSPITAL CORPORATION (US) | 2020-06-30 | — | — | US | disclosed |
| US-20180215721-A1 | TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS | THE GENERAL HOSPITAL CORPORATION | 2018-08-02 | — | — | US | disclosed |
| WO-2017053706-A1 | TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS | THE GENERAL HOSPITAL CORPORATION (US) | 2017-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696642-B2 | TEAD transcription factor autopalmitoylation inhibitors | TEAD1, TEAD2, TEAD3 | MEN1 3771/4885KMT2A 641/4885CYP2C9 4707/4885 |
| US-20180215721-A1 | TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS | TEAD1, TEAD2, TEAD3 | MEN1 3771/4885KMT2A 641/4885CYP2C9 4707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.